Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Pelka

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Heliyon|June 17, 2024
Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic virusesKevin M Coombs, Kathleen K M Glover, Raquel Russell, et al.
Virology|October 26, 2005
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectorsJohn A Howe, Peter Pelka, Doug Antelman, et al.
Immunology and Cell Biology|February 19, 2016
A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for functionKyle E Novakowski, Angela Huynh, SeongJun Han, et al.
Journal of Virology|February 4, 2012
Characterization of the 55-residue protein encoded by the 9S E1A mRNA of species C adenovirusMatthew S Miller, Peter Pelka, Gregory J Fonseca, et al.
Journal of Virology|June 16, 2026
A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse modelZhujun Ao, Robert Vendramelli, Maryann Buyu, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Heliyon|June 17, 2024
Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic virusesKevin M Coombs, Kathleen K M Glover, Raquel Russell, et al.
Virology|October 26, 2005
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectorsJohn A Howe, Peter Pelka, Doug Antelman, et al.
Immunology and Cell Biology|February 19, 2016
A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for functionKyle E Novakowski, Angela Huynh, SeongJun Han, et al.
Journal of Virology|February 4, 2012
Characterization of the 55-residue protein encoded by the 9S E1A mRNA of species C adenovirusMatthew S Miller, Peter Pelka, Gregory J Fonseca, et al.
Journal of Virology|June 16, 2026
A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse modelZhujun Ao, Robert Vendramelli, Maryann Buyu, et al.
Pageof 4